-
Signature
-
/s/ Brad Brubaker, Attorney-in-Fact
-
Issuer symbol
-
PATH
-
Transactions as of
-
15 Dec 2025
-
Net transactions value
-
-$725,080
-
Form type
-
4
-
Filing time
-
17 Dec 2025, 17:03:40 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Dines Daniel |
CEO and Chairman, Director, 10%+ Owner |
C/O UIPATH, INC., ONE VANDERBILT AVENUE, 60TH FLOOR, NEW YORK |
/s/ Brad Brubaker, Attorney-in-Fact |
17 Dec 2025 |
0001855767 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PATH |
Class A Commmon Stock |
Conversion of derivative security |
$0 |
+9,615,297 |
|
$0.000000 |
9,615,297 |
15 Dec 2025 |
See Footnote |
F1, F2, F3 |
| transaction |
PATH |
Class A Commmon Stock |
Sale |
$725,080 |
-45,000 |
-0.16% |
$16.11 |
28,883,585 |
17 Dec 2025 |
Direct |
F4, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PATH |
Class B Common Stock |
Conversion of derivative security |
$0 |
-9,615,297 |
-13% |
$0.000000 |
64,690,706 |
15 Dec 2025 |
Class A Common Stock |
9,615,297 |
$0.000000 |
See Footnote |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: